Abstract:DNA mismatch repair (MMR) plays an important role in maintaining genome stability. Defects in MMR lead to certain types of cancer syndrome, including hereditary non‐polyposis colorectal cancer. MSH2 is a key component in MMR, and it interacts with MSH6 and MSH3 to form the MutSα and MutSβ heterodimers. Recent studies have shown that the half‐life of MSH2 is regulated by HDAC6‐catalyzed acetylation or ubiquitylation on lysine (K) residues 249, 332, 819 and 892. To determine the effect of HDAC6 on MMR function, nuclear extracts derived from mouse embryotic fibroblasts(MEFs) that are proficient and deficient in HDAC6 were examined for MMR activity using a functional in vitro assay. We demonstrate here that HDAC6‐deficient MEFs exhibit an MMR activity that is more active than that in HDAC6‐proficient MEFs, suggesting that HDAC6 negatively regulates MMR function. To distinguish if the reduced MMR activity by HDAC6 is due to acetylation or ubiquitylation of MSH2, K249, K332, K819 and K892(4K) of MSH2 were substituted for glutamines(4KQ) or arginines(4KR), which mimic acetylation or mimic deacetylation status as well as making the protein unubiquitinated, respectively. The resulting MSH2‐4KQ and MSH2‐4KR were allowed to form MutSα‐4KQ and MutSα‐4KR, and tested for their biochemical activities, including mismatch binding, ATP/ADP binding, ATPase, and sliding along the DNA helix. Our results show that in comparison with wild type MutSα, both MutSα‐4KQ and MutSα‐4KR show reduced biochemical activities. However, MutSα‐4KQ appears to be more active than MutSα‐4KR in each activity examined. These results suggest that HDAC6 negatively regulates MSH2 function, probably through ubiquitylation, which either leads to MSH2 degradation via proteasome or directly inhibits MSH2 activity.

Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2.

targeted ubiquitination and destruction of HDAC 2 Mule determines the apoptotic response to HDAC inhibitors by Material Supplemental

Mule/ARF-BP1, a BH3-Only E3 Ubiquitin Ligase, Catalyzes the Polyubiquitination of Mcl-1 and Regulates Apoptosis

HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression

The E3 Ubiquitin Ligase Mule Acts Through the ATM–p53 Axis to Maintain B Lymphocyte Homeostasis

The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.

Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15

Histone H3K4 methyltransferase Mll1 regulates protein glycosylation and tunicamycin-induced apoptosis through transcriptional regulation.

E3 Ubiquitin Ligase Mule Ubiquitinates Miz1 And Is Required For Tnf Alpha-Induced Jnk Activation

Interplay Between Mdm2 And Hipk2 In The Dna Damage Response

Over-expression of Ubiquitin Carboxy Terminal Hydrolase-L1 Induces Apoptosis in Breast Cancer Cells.

HDAC4 Inhibition Disrupts TET2 Function in High-Risk MDS and AML

DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation.

Regulation of MSH2 Activity by Acetylation and Ubiquitylation

Acetylation Of P53 Inhibits Its Ubiquitination By Mdm2

Combined inhibition of HDAC and DNMT1 induces p85α/MEK-mediated cell cycle arrest by dual target inhibitor 208 in U937 cells

Deregulation of Cdc2 Kinase Induces Caspase-3 Activation and Apoptosis

Regulation of Histone Acetyltransferase TIP60 Function by Histone Deacetylase 3

Mutant Huntingtin Protein Induces MLH1 Degradation, DNA Hyperexcision, and Cgas-Sting- Dependent Apoptosis

Targeted Polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP Ligases in Response to DNA Damage

Targeting Matrix Metallopeptidase 2 by Hydroxyurea Selectively Kills Acute Myeloid Mixed-Lineage Leukemia